Literature DB >> 30354393

Gout, Xanthine Oxidase Inhibition, and Cardiovascular Outcomes.

William B White1.   

Abstract

Keywords:  Editorials; allopurinol; cardiovascular outcomes; clinical trial; febuxostat; gout

Mesh：

Substances：

Year:  2018        PMID： 30354393     DOI： 10.1161/CIRCULATIONAHA.118.036148

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

1.  Uric acid and xantine-oxidase inhibitors in patients with gout: A re-assessment and an update.

Authors:  Claudio Borghi; Krzysztof Narkiewicz; Giuseppe Mancia
Journal:  Cardiol J       Date:  2019       Impact factor: 2.737

Review 2.  Biomarkers of Oxidative Stress Tethered to Cardiovascular Diseases.

Authors:  Poojarani Panda; Henu Kumar Verma; Saikrishna Lakkakula; Neha Merchant; Fairrul Kadir; Shamsur Rahman; Mohammad Saffree Jeffree; Bhaskar V K S Lakkakula; Pasupuleti Visweswara Rao
Journal:  Oxid Med Cell Longev       Date:  2022-06-24       Impact factor: 7.310

Review 3.  Emerging medical therapies in crush syndrome - progress report from basic sciences and potential future avenues.

Authors:  Ning Li; Xinyue Wang; Pengtao Wang; Haojun Fan; Shike Hou; Yanhua Gong
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.